A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer
- 1 August 2001
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 33 (2-3) , 259-265
- https://doi.org/10.1016/s0169-5002(01)00189-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy RegimensJournal of Clinical Oncology, 2000
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyJournal of Clinical Oncology, 2000
- Phase I study on docetaxel and ifosfamide in patients with advanced solid tumoursBritish Journal of Cancer, 1998
- Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.Journal of Clinical Oncology, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?Journal of Clinical Oncology, 1993
- Toxicity Grading Criteria of the Japan Clinical Oncology GroupJapanese Journal of Clinical Oncology, 1993
- Relationships between the structure of taxol analogs and their antimitotic activityJournal of Medicinal Chemistry, 1991
- Promotion of microtubule assembly in vitro by taxolNature, 1979